| Literature DB >> 32560684 |
Sabreen Ezzat Fadl1, Ghada Ahmed El-Gammal2, Osama Atia Sakr3, Aly A B S Salah4, Ayman Ali Atia5, Abdelbary Mohammed Prince6, Abdelhaleem Mohamed Hegazy7.
Abstract
BACKGROUND: Using probiotics have become popular. They are considered an alternative to Antibiotic Growth Promoters (AGP). Probiotics are supplemented into animal feed for improving growth performance along with preventing and controlling enteric pathogens. The aim of this work was to study the impact of dietary supplementation of Mannan-oligosaccharide and β-Glucan (Agrimos®) on broiler challenged with Escherichia coli O78 (E. coli O78 - marked with an antibiotic (320 μg ciprofloxacin/ml broth) on growth performance, serum biochemistry, immune organs-histopathology, E-coli colonization, and hepatic transcripts of Tumor necrosis factor-alpha (TNF-α) and Nuclear factor-kappa B (NF-ϰB). A total of 125 one-day-old chicks were used for conducting the experiment. Five one-day-old chicks were slaughtered for measuring the initial weight of the lymphoid tissue. The remaining chicks (120) were allotted into four groups according to Mannan-oligosaccharide and β-Glucan supplementation, and E. coli infection. The data were analyzed using SPSS version 16.Entities:
Keywords: Agrimos; Antioxidant; Gene expression; Growth performance; Histopathology; Immunostimulant
Mesh:
Substances:
Year: 2020 PMID: 32560684 PMCID: PMC7304200 DOI: 10.1186/s12917-020-02423-2
Source DB: PubMed Journal: BMC Vet Res ISSN: 1746-6148 Impact factor: 2.741
The mortality rate of broiler chicken infected with E. coli and fed on agrimos® at 35 days (n = 30)
| Groups | Control noninfected | Control infected | Agrimos® noninfected | Agrimos® infected |
|---|---|---|---|---|
| Total No. | 30 | 30 | 30 | 30 |
| Dead No. | 1 | 2 | 0 | 1 |
| Survival % | 96.67 | 93.33 | 100 | 96.67 |
| Mortality % | 3.33 | 6.67 | 0 | 3.33 |
Growth performance of broiler chicken infected with E. coli and fed on agrimos® at 35 days (n = 30)
| Groups | Control noninfected | Control infected | Agrimos® noninfected | Agrimos® infected |
|---|---|---|---|---|
| Initial body weight (g/chick) | 45.33 ± 0.88a | 45 ± 1.00a | 45.67 ± 0.88a | 45.67 ± 1.20a |
| Final body weight (g/bird) | 1544.33 ± 1.76b | 1358.67 ± 2.03c | 1736.33 ± 2.33a | 1547.00 ± 1.73b |
| Total Weight gain (g/bird) | 1499 ± 1.53b | 1313.67 ± 2.19c | 1690.67 ± 1.45a | 1501.33 ± 0.67b |
| FCR value | 1.67 ± 0.005b | 1.87 ± 0.006a | 1.54 ± 0.003c | 1.66 ± 0.003b |
Values are expressed as mean ± standard errors. Means in the same row (a-c) with different letters significantly differ at (p ≤ 0.05)
Serum liver function of broiler chicken infected with E. coli and fed on agrimos® at 35 days (n = 5)
| Groups | Control noninfected | Control infected | Agrimos® noninfected | Agrimos® infected |
|---|---|---|---|---|
| ALT (u/l) | 19.33 ± 0.88b | 26.33 ± 0.88a | 18.67 ± 0.88b | 20.67 ± 0.67b |
| AST (u/l) | 53.33 ± 1.76b | 92.67 ± 0.88a | 51.33 ± 0.88b | 52.67 ± 1.45b |
| Total protein (g/dl) | 2.27 ± 0.08b | 1.9 ± 0.06c | 2.9 ± 0.12a | 2.7 ± 0.11a |
| Albumin (g/dl) | 1.20 ± 0.02a | 0.47 ± 0.05b | 1.24 ± 0.03a | 1.21 ± 0.01a |
| Globulin (g/dl) | 1.06 ± 0.09b | 1.43 ± 0.01a | 1.66 ± 0.12a | 1.49 ± 0.11a |
Values are expressed as mean ± standard errors. Means in the same row (a-c) with different letters significantly differ at (p ≤ 0.05)
Serum antioxidant of broiler chicken infected with E. coli and fed on agrimos® at 35 days (n = 5)
| Groups | Control noninfected | Control infected | Agrimos® noninfected | Agrimos® infected |
|---|---|---|---|---|
| MDA (n.mol/l) | 0.65 ± 0.02c | 1.17 ± 0.08a | 0.65 ± 0.01c | 0.8 ± 0.03b |
| CAT (u/ml) | 12.7 ± 0.01b | 9.73 ± 0.15c | 15.36 ± 0.13a | 13.03 ± 0.09b |
| SOD (u/ml) | 12.18 ± 0.0c | 9.37 ± 0.0d | 17.2 ± 0.89a | 15.0 ± 0.0b |
Values are expressed as mean ± standard errors. Means in the same row (a-c) with different letters significantly differ at (p ≤ 0.05)
HI titer for ND at different periods (n = 5)
| Groups | Control infected | Control noninfected | Agrimos® infected | Agrimos® noninfected |
|---|---|---|---|---|
No difference between item carries the same letter in the same row
GM Geometric mean, CV Coefficient of variation, p. v Post vaccination
Colonization of E. coli and rate of shedding as judged by intestinal colonization (n = 5)
| R. T. swab | Liver | G. bladder | Spleen | Fecal swab | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| + | T | % | + | T | % | + | T | % | + | T | % | + | T | % | |
| 6 | 9 | 67 | 4 | 9 | 44 | 2 | 9 | 22 | 4 | 9 | 44 | 8 | 15 | 53 | |
| 2 | 9 | 22 | 3 | 9 | 33 | 2 | 9 | 22 | 1 | 9 | 11 | 5 | 15 | 33 | |
R. T. swab Respiratory tract swab aE. coli + A = E. coli + Agrimos®
The weight of Immune organs of broilers at 35 days (n = 5)
| Organs | Treatment and age | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| C- | C+ | A- | A+ | |||||||||
| Zero- day | At 15 days | At 35 days | Zero-day | At 15 days | At 35 days | Zero- day | At 15 days | At 35 days | Zero- day | At 15 days | At 35 days | |
0.287 ± 0.033Y | 0.59 ± 0.012 bX | 0.134 ± 0.008 BZ | 0.287 ± 0.033Y | 0.377 ± 0.013 cX | 0.069 ± 0.006 CZ | 0.287 ± 0.033Y | 0.65 ± 0.006aX | 0.282 ± 0.012AY | 0.287 ± 0.033Y | 0.627 ± 0.009 aX | 0.276 ± 0.011 AY | |
0.036 ± 0.007Y | 0.046 ± 0.003 dY | 0.132 ± 0.011 BX | 0.036 ± 0.007Z | 0.094 ± 0.004 cX | 0.056 ± 0.006 CY | 0.036 ± 0.007Z | 0.11 ± 0.006 bY | 0.229 ± 0.009 AX | 0.036 ± 0.007Z | 0.127 ± 0.003 aY | 0.159 ± 0.005 BX | |
0.157 ± 0.024Y | 0.329 ± 0.003 bX | 0.121 ± 0.004 CY | 0.157 ± 0.024Y | 0.259 ± 0.01 cX | 0.064 ± 0.006 DZ | 0.157 ± 0.024Y | 0.394 ± 0.003 aX | 0.355 ± 0.014 AX | 0.157 ± 0.024Y | 0.338 ± 0.017 bX | 0.317 ± 0.013 BX | |
Values are expressed as mean ± standard errors. Means in the same row (a-d), (A-C) and (X-Z) with different letters significantly differ at (p ≤ 0.05)
T Thymus B. W. Body weight, S Spleen, B Bursa
Fig. 1Thymus of one-day-old chicken (A1). Thymus of control non-infected group at 35 days (A2). Thymus of control infected group at 35 days (A3). Thymus of agrimos non-infected group at 35 days (A4). Thymus of agrimos infected group at 35 days (A5). Bursa of one-day-old chicken (B1). Bursa of control non-infected group at 35 days (B2). Bursa of control infected group at 35 days (B3). Bursa of agrimos non-infected group at 35 days (B4). Bursa of agrimos infected group at 35 days (B5). Spleen of one-day-old chicken (C 1). Spleen of control non-infected group at 35 days (C 2). Spleen of control infected group at 35 days (C 3). Spleen of agrimos non-infected group at 35 days (C 4). Spleen of agrimos infected group at 35 days (C 5)
Fig. 2a. showing normal bursa of Fabricius. Control negative one-day-old chick. b. showing normal thymus. Control negative one-day-old chick. C. bursa of Fabricius showing variable degree of epithelial hyperplasia (arrow a) and ulceration (arrow b). Control infected group at 15 days post infection. d. Bursa of Fabricius showing variable degree of epithelial hyperplasia (arrow a) associated with degeneration and ulceration (arrow b). Control infected group at 15 days post infection. e. Bursa of Fabricius showing variable degree of epithelial hyperplasia associated with degeneration and sub cortical fibrous tissues proliferation. Control infected group at 15 days post infection. f. Thymus showing numerous holes on the cortex and medulla. Control infected group at 15 days post infection. H&E. a and b X 100 other Figs. X 200
Fig. 3a. Liver showing focal area of round cells aggregation. Control infected group at 35 days post infection. b. Intestine (duodenum) showing hyperplasia of the epithelial lining the intestinal villi associated with vaculation. Control infected group at 35 days. . bursa of Fabricius showing normal atypical fold. Agrimos® non-infected group at 15 days. d. Bursa of Fabricius showing pores within the cortex. Agrimos® non-infected group at 35 days. e. Thymus showing thrombus formation (arrow). Agrimos® non-infected group at 15–35 days. f. Caecal tonsil showing epithelial sloughing (arrow). Agrimos® non-infected group at 15–35 days. H&E. X 200 for all figures except c X 100
Fig. 4a. Caecal tonsil showing normal lymphoid aggregation (arrow). Agrimos® non-infected group at 15–35 days. b. Caecal tonsil showing necrotic cyst (arrow). Agrimos® non-infected group at 15–35 days. c. Spleen showing normal appearance. Agrimos® non-infected group at 15–35 days. d. Liver showing mild focal areas of round cells aggregation (arrow). Agrimos® non-infected group at 15–35 days. e. Bursa of Fabricius showing inter follicular edema. Agrimos® infected group at 15 days post infection. f. Thymus showing numerous cortical holes in cortex and medulla (these holes containing apoptotic bodies). Agrimos® infected group at 15 days post infection. H&E. X 200 for all figures except e X 100
Histopathological assessment of dietary agrimos® supplementation on E. coli challenged broiler chicken ((n = 10)
| Lesions | Infected group | Agrimos non-infected group | Agrimos infected group | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| At 15 days | At 35 days | At 15 days | At 35 days | At 15 days | At 35 days | |||||||||||||
| B | T | S | B | T | S | B | T | S | B | T | S | B | T | S | B | T | S | |
| Sub capsular heterophilic aggregation | – | Normal | – | Normal | Normal | Normal | Normal | Normal | Normal | Normal | – | Normal | Normal | – | Normal | |||
| Sub and interstitial edema | – | – | + | + | ||||||||||||||
| Interstitial hemorrhages | – | – | – | + | ||||||||||||||
| Interstitial connective tissue proliferation | – | – | – | – | ||||||||||||||
| Epithelial folding and lobulation | + | – | – | – | ||||||||||||||
| Epithelial hyperplasia | + | + | + | + | ||||||||||||||
| Epithelial degeneration and/or necrosis | + | + | – | + | ||||||||||||||
| Reduction in size and numbers of follicles | – | – | – | – | ||||||||||||||
| Follicular atrophy or cortical atrophy | – | – | + | – | + | + | ||||||||||||
| Follicular cyst and necrosis | – | – | – | + | ||||||||||||||
| Lymphocytic depletion | – | – | – | + | ||||||||||||||
| Appearance of holes in medulla | – | + | – | ++ | – | – | ||||||||||||
| Reticular cells proliferation | – | – | – | – | ||||||||||||||
| Vasculitis | – | – | – | – | ||||||||||||||
| Cortical necrosis | – | – | – | – | ||||||||||||||
| Apoptotic bodies and/or karyorhexis | – | + | – | – | – | |||||||||||||
| Hyalinization and thrombosis of blood vessels | – | – | – | – | ||||||||||||||
+++ Sever ++ Moderate + Mild B = Bursa T = Thymus S=Spleen
Incidence of pathological changes in organs at different periods (n = 10)
| Groups | Infected group | Agrimos non-infected group | Agrimos infected group | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Periods | At 15 days | At 35 days | At 15 days | At 35 days | At 15 days | At 35 days | ||||||||||||||||||
| Parameter | N | A | T | % | N | A | T | % | N | A | T | % | N | A | T | % | N | A | T | % | N | A | T | % |
| B | 2 | 2 | 4 | 50 | 1 | 3 | 4 | 75 | 4 | 1 | 5 | 20 | 4 | 1 | 5 | 20 | 2 | 2 | 4 | 50 | 2 | 2 | 4 | 50 |
| T | 4 | 0 | 4 | 0 | 2 | 2 | 4 | 50 | 3 | 2 | 5 | 40 | 4 | 1 | 5 | 20 | 3 | 1 | 4 | 25 | 3 | 1 | 4 | 25 |
| S | 3 | 1 | 4 | 25 | 4 | 0 | 4 | 0 | 5 | 0 | 5 | 0 | 5 | 0 | 5 | 0 | 4 | 0 | 4 | 0 | 4 | 0 | 4 | 0 |
B Bursa T Thymus S Spleen, N Normal A Abnormal T Total % = Ratio
Fig. 5Changes in the gene expression of NF (right) and TNF-α (left) among experimental groups. C (negative control), C+ (positive control), A (agrimos® treated without infection), A+ (agrimos® treated group with E. coli infection)
Experimental feeding program
| Physical composition | Basal diet (0–3) weeks | Basal diet (3–6) weeks |
|---|---|---|
| Yellow corn | 55 | 61.35 |
| Soybean meal 48% | 32 | 30.6 |
| Corn gluten 62% | 4.42 | 0 |
| Sunflower oil | 4.4 | 4.4 |
| Methionine | 0.16 | 0.08 |
| Dicalcium phosphate | 1.85 | 1.4 |
| Lime stone | 1.25 | 1.3 |
| Choline 60% | 0.22 | 0.17 |
| Common salt | 0.4 | 0.4 |
| Premixa | 0.3 | 0.3 |
| ME Kcal/kg | 3218.5 | 3229.7 |
| Crude protein | 23.02 | 20.03 |
| Calcium | 1 | .9 |
| Available phosphorus | 0.45 | 0.35 |
| Lysine | 1.1 | 1 |
| Methionine + cysteine | 0.9 | .72 |
| Choline | 1300 mg/1 kg | 1000 mg/1 kg |
a The used premix (Multivita Co.) composed of retinol 12,000,000 IU, cholecalciferol 2,200,000 IU, tocopherol 10,000 mg, menadione 2000 mg, thiamin 1000 mg, riboflavin 5000 mg, pyridoxal 1500 mg, cobalamin 10 mg, Niacin 30,000 mg, Biotin 50 mg, Folic acid 1000 mg, Pantothenic acid 10,000 mg, Iron 30,000 mg, Manganese 60,000 mg, Copper 4000 mg, Zinc 50,000 mg, Iodine 1000 mg, Cobalt 100 mg, Selenium 100 mg, calcium carbonate (CaCO3) carrier to 3000 g
Primers used for qPCR analysis
| Primer | Sequence | Reference |
|---|---|---|
for: 5′-GAGCTGTGGGGAGAACAAAAGGA-3′ Rev.: 5′-TTGGCCCTTGAAGAGGACCTG-3′ | ||
for: 5′-CAAGGCAGCAAATAGACGAG-3′ Rev.: 5′-GTTGAGAGTTAGCAGTGAGGCA-3’ | ||
For- 5’CCTCTCTGGCAAAGTCCAAG3′ Rev- 5’CAACATCAAATGGGCAGATG3’ |
TNF-α: Tumor necrosis factor-alpha, NF-ϰB: Nuclear factor-kappa B, GAPDH: Glyceraldehyde-3 phosphate dehydrogenase